About
Holds an M.D. from Erasmus University Rotterdam and a Ph.D. in cancer biomedicine from the Norwegian Radiumhospital. She has broad healthcare and life sciences experience as a management consultant at EY, in medical and commercial roles at Novartis, clinical oncology practice, and as a healthcare equity analyst at Arctic Securities before co-founding and leading P53.
Contact· self-published, not guessed
Experience
- p53Founding Partnercurrent2018 — presentOslo Area, Norway
- Nykode TherapeuticsBoard Membercurrent2025 — present
- Serenatis BioBoard Membercurrent2025 — presentCambridge, England, United Kingdom
- Teitur TrophicsBoard Membercurrent2023 — presentMiddle Jutland, Denmark
- Calluna PharmaBoard Membercurrent2024 — present
- PacertoolBoard Member2022 — 2023
- Arxx TherapeuticsBoard Member/Vice Chair Board Directors2021 — 2023
- Arxx TherapeuticsChair Of The Board Arxx Therapeutics2019 — 2021
- Creative Destruction LabMentor2020 — 2023Oxford, England, United Kingdom
- Gentian Diagnostics ASBoard Member2019 — 2023
- Nykode TherapeuticsBoard Member2019 — 2021
- Arctic Securities ASEquity Research Analyst Healthcare/Biotechnology2015 — 2018Norway
- EYManager EY Advisory2014 — 2015Oslo Area, Norway
- NovartisMedical and Commercial roles2011 — 2014Scandinavia
- Oslo universitetssykehus HFResident Physician, Oncology2010 — 2011
- Oslo universitetssykehus HFMedical Intern2009 — 2010
- Oslo universitetssykehus HFPhD student2005 — 2009
Skills & more
Analytical Skills2Strategy3Cancer Research7Clinical Development4Oncology12Medical Affairs3Brand Management3Immunology4Biotechnology1Business Strategy1Clinical Research2Clinical Trials2
+4 more
Market AccessHealthcareInnovationPharmaceutical IndustryLanguages Dutch · English · German · Norwegian
- PRINCE2 Foundation - Project Management
- Innovation ("Innovasjon og Nytenkning") — invalid4089
- Project Management — Novartis
- ICH E6 Good Clinical Practice — Novartis
- M1 Leading at the Frontline — Novartis
From Susanne's professional profile.
Colleagues at P53 Invest
Frequently asked questions
- Who is Susanne Stuffers?
- Holds an M.D. from Erasmus University Rotterdam and a Ph.D. in cancer biomedicine from the Norwegian Radiumhospital. She has broad healthcare and life sciences experience as a management consultant at EY, in medical and commercial roles at Novartis, clinical oncology practice, and as a healthcare equity analyst at Arctic Securities before co-founding and leading P53.
- Where does Susanne Stuffers work?
- Susanne Stuffers is CEO & founding partner at P53 Invest.
- Where did Susanne Stuffers go to school?
- Susanne Stuffers studied at University of Oslo (MD, Medicine); University of Oslo (PhD, Molecular Medicine (Biochemistry & Cell Biology)); Erasmus University Rotterdam (Doctorandus, Medicine).
Same school
Also attended University of Oslo59
Line Svinndal LorentsenInvestor at InvestinorPatrickInvestor at InvestinorNina MahmoudpourGeneral Counsel & Chief of Staff at Type One VenturesOle RuchManaging Partner at NordstarMarianne UtengManaging Director at Novartis Venture FundAndreas SlettvollVenture Partner at World Fund
.avif)
+ 53 more
Also attended Erasmus University Rotterdam258
Alessandro TavecchioPartner at P101 VenturesDick SietsesInvestment Partner Health at Capricorn Venture PartnersKonradInvestment Team at Hummingbird VenturesProf. Dr. Elbert DijkgraafBestuurslid at NoaberJohanneke van de Scheur-BaanBestuurslid at NoaberMaarten FischerHead of Programs at Noaber
+ 252 more
Shared employers
Also worked at Nykode Therapeutics1
Also worked at Serenatis Bio1
Also worked at Calluna Pharma4
Also worked at Creative Destruction Lab166
Greg RudinBoard Partner at Menlo VenturesIsabel FoxHead of Investor Relations at Hoxton VenturesAngelaGeneral Partner at Version One VenturesMatt StevensEntrepreneur in Residence at Tech Square VenturesChristophe JurczakPartner at QuantonationShila Nieves BurneyManaging Partner at Zane Venture Fund
+ 160 more